Summary
Down syndrome (DS) is the most common human chromosomal abnormality caused by an extra copy of chromosome 21 and characterized clinically by somatic anomalies, mental retardation and precocious dementia. The phenotype of DS is thought to result from overexpression of a gene or genes located on the triplicated chromosome or chromosome region. Reports that challenge this notion, however, have been published. To add to this body of evidence, the expression of β-amyloid precursor protein (APP), ETS-2 and collagen α1 (VI) chain precursor, encoded on chromosome 21, was investigated in fetal brain by western blot and two-dimensional electrophoresis (2-DE). Western blot detected APP and ETS-2 that migrated at -75 and 50kDa, respectively. Subsequent densitometric analysis of APP and ETS-2 immuno-reactivity did not produce any significant change between controls and DS. Since the metabolic fate of APP determines the propensity of amyloid β production, the expression of the secreted forms of APP (sAPP) had been examined. Neither the expression of sAPPaα nor sAPPß showed any detectable changes among the two groups. Collagen α1(VI) chain precursor, a protein resolved as a single spot on 2D gel was identified by matrix associated laser desorption ionization mass spectroscopy. Quantitative analysis of this spot using the 2D Image Master software revealed a significant decrease in fetal DS (P < 0.01) compared to controls. Linear regression analysis did not show any correlation between protein levels and age. The current data suggest that overexpression per se can not fully explain the DS phenotype.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antonarakis SE (1998) 10 years of genomics, chromosome 21, and Down syndrome. Genomics 51: 1–16
Arai Y, Suzuki A, Mizuguchi M, Takashima S (1997) Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brains. Brain Dev 19: 290–294
Baffico M, Perroni L, Rasore-Quartino A, Scartezzini P (1989) Expression of the human ETS-2 oncogene in normal fetal tissues and in the brain of a fetus with trisomy 21. Hum Genet 83: 295–296
Berndt P, Hobohm U, Langen H (1999) Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis 20: 3521–3526
Bhat NK, Fisher RJ, Fujiwara S, Ascione R, Papas TS (1987) Temporal and tissue specific expression of mouse ETS genes. Proc Natl Acad Sci USA 84: 3161–3165
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254
Brown JC, Timpl R (1995) The collagen superfamily. Int Arch Allerg Appl Immunol 107: 484–490
Chu M-L, Conway D, Pan T-C, Baldwin C, Mann K, Deutzmann R, Timpl R (1988) Amino acid sequence of the triple helical domain of the human collagen type VI. J Biol Chem 263: 18601–18606
de Haan JB, Wolvetang EJ, Cristiano F, Iannello R, Bladier C, Keiner MJ, Kola I (1997) Reactive oxygen species and their contribution to pathology in Down syndrome. Adv Pharmacol 38: 379–402
Epstein CJ (1995) Down Syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn, vol. I. McGraw Hill,New York, pp 749–794
Fountoulakis M, Langen H (1997) Identification of proteins by matrix assisted laser desorption ionization mass spectrometry following in-gel digestion in low salt, nonvolatile buffer and simplified peptide recovery. Anal Biochem 250: 153–156
Furthmayr H, Wiedemann H, Timpl R, Odermatt E, Engel J (1983) Electron microscopical approach to a structural model of intima collagen. Biochem J 211: 303–311
Golaz J, Charnay Y, Vallet P, Bouras C (1991) Alzheimer’s disease and Down syndrome.Some recent etiopathogenic data. Encephale 17: 29–31
Greber-Platzer S, Schatzmann-Turhani D, Wollenek G, Lubec G (1998) Evidence against the current hypothesis of “gene dosage effects” of trisomy 21: ETS-2, encoded on chromosome 21 is not overexpressed in hearts of patients with Down syndrome.Biochem Biophys Res Commun 254: 395–399
Greber-Platzer S, Schatzmann-Turhani D, Cairns D, Balcz B, Lubec G (1999) Expression of the transcription factor ETS-2 in brain of patients with Down syndrome-evidence against the overexpression gene hypothesis. J Neural Transm [Suppl] 57: 269–281
Griffin WST, Sheng JG, McKenzie LE, Royston MC, Gentleman SM, Brumback RA,Cork LC, Del Bigio MR, Roberts GW, Mrak RE (1998) Life-long expression of S-100ß in Down’s syndrome: implication for Alzheimer pathogenesis. Neurobiol Aging 19: 401–405
Hatori M, Fujiyama A, Taylor TD, Watanabe H, Yada T, Park H-S et al (2000) The DNA sequence of human chromosome 21. Nature 405: 311–319
Howlett DR, James S, Allsop D, Roberts GW (1995) The biology and molecular pathology of β.amyloid protein. In: Dawbarn D, Allen SJ (eds) Neurobiology of Alzheimer’s disease. BIOS Scientific Publishers, Oxford, pp 9–49
Jander R, Raterberg J, Glanville RW (1983) Further characterization of the three polypeptide chains of bovine and human short-chain collagen (intima collagen). Eur J Biochem 133: 39–46
Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grezeschik K-H,Multhaup G, Beyreuther K, Müller-Hill B (1987) The precursor of Alzheimer’s amyloid A4 protein resembles a cell surface receptor. Nature 325: 733–736
Klewer SE, Krob SL, Kolker SJ, Kitten GT (1998) Expression of type VI collagen in the developing mouse heart. Dev Dyn 211: 248–255
Knupp C, Squire JM (2001) A new twist in the collagen story - the type VI segmented supercoil. EMBO J 20: 372–376
Lamande SR, Shields KA, Kornberg AJ, Shield LK, Bateman JF (1999) Bethlem myopathy and engineered collagen VI triple helical deletion prevent intracellular multimer assembly and protein secretion. J Biol Chem 274: 21817–21822
Langen H, Röder D, Juranville JF, Fountoulakis M (1997) Effect of the protein application mode and the acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis. Electrophoresis 18: 2085–2090
Levine JM, Nishiyama A (1996) The NG-2 chondrotin sulfate proteoglycan: a multi functional proteoglycan associated with immature cells. Perspect Dev Biol 3: 545–559
Lubec G, Labudova O, Cairns N, Fountoulakis M (1999) Increased glyceraldehyde-3-phosphate dehydrogenase levels in brain of patients with Down syndrome. Neurosci Lett 260: 141–145
Maraoulakou IG, Papas TS, Green JE (1994) Differential expression of ETS-1 and ETS-2 genes during murine embriogenesis. Oncogene 9: 1551–1565
Mills J, Reiner PB (1999) Regulation of amyloid precursor protein cleavage. J Neurochem 72: 443–460
Neve RL, Finch EA, Dawes LR (1988) Expression of the Alzheimer’s amyloid precursor gene transcript in the human brain. Neuron 1: 669–677
Neve RL, McPhie DL, Chen Y (2000) Alzheimer’s disease: a dysfunction of the amyloid precursor protein. Brain Res 886: 54–66
Oyama F, Cairns NJ, Shaimada H, Oyama R, Titani K, Inara Y (1994) Down’s syndrome: upregulation of β-amyloid protein precursor and tau mRNAs and their defective coordination. J Neurochem 62: 1062–1066
Pellegrini L, Passer BJ, Tabaton M, Ganjei JK, D’Adamio L (1999) Alternative non-secretase processing of Alzheimer’s β-amyloid precursor protein during apoptosis by caspase-6 and -8. J Biol Chem 274: 21011–21016
Pritchard MA, Kola I (1999) The “gene dosage effect” versus the “amplified developmental instability” hypothesis in Down syndrome. J Neural Transm [Suppl] 57: 293–303
Shapiro BL (1983) Down syndrome - a disruption of homeostasis. Am J Med Genet 14: 241–269
Shapiro BL (1999) The Down syndrome critical region. J Neural Transm [Suppl] 57: 41–60
Sumarsono SH, Wilson TJ, Tymms MJ, Venter D, Corrick CM, Kola R, Lahoud M, Papas TS, Seth A, Kola I (1996) Ets transgenic mice develop skeletal abnormalities analogous to those found in Down syndrome. Nature 379: 534–537
Teller JK, Russo C, DeBusk LM, Angelini G, Zaccheo D, Dagna-Bricarelli F, Scartezzini P, Bertolini S, Mann DMA, Tabaton M, Gambetti P (1996) Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down’s syndrome. Nature Med 2: 93–95
Trüeb B, Bornstein P (1984) Characterization of the precursor form of type VI collagen. J Biol Chem 259: 8597–8604
von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH (1998) Collagen type VI expression in the skin of trisomy 21 fetuses. Obstet Gynecol 91: 319–323
Wasco W, Tanzi RE (1995) Molecular genetics of amyloid and apolipoprotein E in Alzheimer’s disease. In: Dawbarn D, Allen SJ (eds) Neurobiology of Alzheimer’s disease. BIOS Scientific Publishers, Oxford, pp 51–76
Wasylyk B, Hahn SL, Giovane A (1993) The ETS family transcription factors. Eur J Biochem 211: 7–18
Weil D, Mattei MG, Passage E, N’Guyen VC, Pribula-Conway D, Mann K, Deutzmann R, Timpl R, Chu ML (1988) Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. Am J Hum Genet 42: 435–445
Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down syndrome. Ann Neurol 17: 278–282
Yoshikai S-I, Sasaki H, Doh-ura K, Furuya H, Sakaki Y (1990) Genomic organization of the human amyloid beta protein precursor gene. Gene 87: 257–263
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag/Wien
About this chapter
Cite this chapter
Engidawork, E., Balic, N., Fountoulakis, M., Dierssen, M., Greber-Platzer, S., Lubec, G. (2001). β-Amyloid precursor protein, ETS-2 and collagen alpha 1 (VI) chain precursor, encoded on chromosome 21, are not overexpressed in fetal Down syndrome: further evidence against gene dosage effect. In: Lubec, G. (eds) Protein Expression in Down Syndrome Brain. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6262-0_28
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6262-0_28
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83704-7
Online ISBN: 978-3-7091-6262-0
eBook Packages: Springer Book Archive